6949.TW
Pell Bio-Med Technology Co., Ltd.
TaiwanTWDEQUITY
Healthcare
DELAYED
Strong sell
-59/100
Last price
45.25
▼ 1.50 (3.21%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
46.60
Prev close
46.75
Day high
47.70
Day low
44.85
Volume
2.32M
Market cap
$59.39B
P/E (TTM)
—
52W range
44.35 – 1,490.00
Day trading desk
Gap from prior close
-0.32%
Prior close 46.75
VWAP
45.55
-0.66% from price
Relative volume
1.27×
Normal
Session range
6.35%
44.85 – 47.70
Position in range
14%
Near session low
ATR (14D)
2.95
6.51% of price
Prior day high
48.90
PDH
Prior day low
46.65
PDL
Bid / ask spread
—
Quote not published
Session volume
4.01M
Avg 3.16M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-10.47%
-12.4%
1M
-39.19%
-40.4%
3M
-95.28%
-99.8%
6M
-92.55%
-110.7%
YTD
-86.77%
-101.0%
1Y
-89.18%
-105.6%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 6949.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$59.39B
Enterprise value$59.57B
Revenue (TTM)$28.93M
Gross profit$-10.42M
EBITDA$-462.61M
Net income$-435.85M
EPS (TTM)$-0.38
Free cash flow$-434.35M
Total cash$2.17B
Total debt$231.52M
Book value / share$1.96
Shares outstanding1.31B
Float684.59M
Short % of float—
Dividend yield0.00%
Beta (5Y)1.33
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book23.08
EV / revenue2,059.39
EV / EBITDA-128.78
Gross margin-36.01%
Operating margin-1221.13%
Profit margin0.00%
Return on equity-24.19%
Return on assets-12.91%
Debt / equity8.20
Current ratio10.07
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $31.42M | $19.63M | $18.03M | $17.16M | +60.1% |
| Operating revenue | $31.42M | $19.63M | $18.03M | $17.16M | +60.1% |
| Cost of revenue | $35.81M | $31.96M | $44.17M | $28.41M | +12.1% |
| Gross profit | -$4.39M | -$12.33M | -$26.14M | -$11.26M | +64.4% |
| Research & development | $252.66M | $266.16M | $239.61M | $142.55M | -5.1% |
| Selling, general & admin | $210.29M | $135.01M | $145.49M | $82.24M | +55.8% |
| Total operating expense | $462.96M | $401.17M | $385.11M | $224.79M | +15.4% |
| Operating income | -$467.35M | -$413.50M | -$411.25M | -$236.04M | -13.0% |
| Net interest income | $9.86M | $13.11M | $5.08M | $907.00K | -24.8% |
| Pre-tax income | -$452.67M | -$395.12M | -$401.24M | -$231.27M | -14.6% |
| Tax provision | $0 | $0 | $2.00K | $0 | — |
| Net income | -$423.94M | -$389.42M | -$398.76M | -$230.13M | -8.9% |
| Net income to common | -$423.94M | -$389.42M | -$398.76M | -$230.13M | -8.9% |
| Basic EPS | -7.23 | -6.83 | -8.55 | -5.82 | -5.9% |
| Diluted EPS | -7.23 | -6.83 | -8.55 | -5.82 | -5.9% |
| EBIT | -$450.63M | -$392.86M | -$398.68M | -$229.91M | -14.7% |
| EBITDA | -$403.51M | -$345.98M | -$353.07M | -$198.87M | -16.6% |
| Basic shares | 58.64M | 57.05M | 46.66M | 39.54M | +2.8% |
| Diluted shares | 58.64M | 57.05M | 46.66M | 39.54M | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $306.70M | $427.37M | $167.68M | $172.40M | -28.2% |
| Cash & short-term investments | $1.31B | $1.14B | $1.11B | $708.40M | +15.4% |
| Accounts receivable | $5.07M | $3.75M | $7.61M | $6.05M | +34.9% |
| Inventory | $6.62M | $6.18M | $3.76M | $4.58M | +7.1% |
| Total current assets | $1.33B | $1.16B | $1.13B | $725.39M | +15.0% |
| Property, plant & equipment | $715.58M | $502.04M | $266.80M | $298.97M | +42.5% |
| Goodwill & intangibles | $2.93M | $1.89M | $2.40M | $2.71M | +55.1% |
| Total assets | $2.11B | $1.74B | $1.42B | $1.04B | +21.1% |
| Total current liabilities | $308.97M | $321.35M | $89.30M | $57.23M | -3.9% |
| Current debt | $100.13M | $200.02M | $0 | $5.15M | -49.9% |
| Total debt | $237.40M | $364.84M | $172.56M | $202.78M | -34.9% |
| Total liabilities | $418.27M | $458.62M | $236.76M | $229.79M | -8.8% |
| Retained earnings | -$1.63B | -$1.21B | -$817.85M | -$419.09M | -35.1% |
| Shareholder equity | $1.42B | $1.18B | $1.17B | $800.94M | +20.5% |
| Working capital | $1.02B | $836.38M | $1.04B | $668.15M | +22.2% |
| Net tangible assets | $1.42B | $1.18B | $1.17B | $798.22M | +20.5% |
| Shares issued | 59.30M | 58.34M | 57.61M | 57.61M | +1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$452.67M | -$395.12M | -$401.24M | -$231.27M | -14.6% |
| Depreciation & amortisation | $47.12M | $46.88M | $45.61M | $31.04M | +0.5% |
| Stock-based compensation | $75.12M | $58.97M | $143.06M | $46.68M | +27.4% |
| Change in working capital | $54.98M | $29.60M | $33.05M | -$7.49M | +85.7% |
| Operating cash flow | -$281.29M | -$260.12M | -$179.99M | -$160.98M | -8.1% |
| Capital expenditure | -$227.61M | -$263.98M | -$16.48M | -$8.49M | +13.8% |
| Investing cash flow | -$497.14M | -$95.51M | -$419.63M | -$550.96M | -420.5% |
| Share buybacks | — | $0 | -$800.00K | $0 | — |
| Financing cash flow | $657.76M | $615.32M | $594.89M | $768.56M | +6.9% |
| Free cash flow | -$508.89M | -$524.10M | -$196.47M | -$169.48M | +2.9% |
| End cash position | $306.70M | $427.37M | $167.68M | $172.40M | -28.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $8.95M | $6.37M | $6.07M | — | $5.87M | $11.94M | +40.5% |
| Operating revenue | $8.95M | $6.37M | $6.07M | — | $5.87M | $11.94M | +40.5% |
| Cost of revenue | $10.75M | $7.57M | $4.72M | — | $7.08M | $7.71M | +41.9% |
| Gross profit | -$1.80M | -$1.21M | $1.35M | — | -$1.21M | $4.23M | -49.2% |
| Research & development | $57.18M | $41.54M | $74.30M | — | $47.47M | $51.34M | +37.7% |
| Selling, general & admin | $50.31M | $46.01M | $101.22M | — | $34.34M | $37.72M | +9.3% |
| Total operating expense | $107.49M | $87.55M | $175.51M | — | $81.81M | $89.07M | +22.8% |
| Operating income | -$109.29M | -$88.75M | -$174.16M | — | -$83.02M | -$84.83M | -23.1% |
| Net interest income | $8.30M | $1.10M | $6.39M | — | $2.09M | $1.36M | +652.4% |
| Pre-tax income | -$100.43M | -$87.17M | -$167.23M | — | -$83.40M | -$77.26M | -15.2% |
| Tax provision | $0 | $0 | $0 | — | $0 | $0 | — |
| Net income | -$88.90M | -$76.58M | -$151.96M | — | -$77.80M | -$75.77M | -16.1% |
| Net income to common | -$88.90M | -$76.58M | -$151.96M | — | -$77.80M | -$75.77M | -16.1% |
| Basic EPS | -1.36 | -1.18 | — | -2.00 | -1.33 | -1.30 | -14.9% |
| Diluted EPS | -1.36 | -1.18 | — | -2.00 | -1.33 | -1.30 | -14.9% |
| EBIT | -$99.50M | -$86.23M | -$169.54M | — | -$81.95M | -$75.79M | -15.4% |
| EBITDA | -$77.90M | -$67.32M | -$157.94M | — | -$70.11M | -$64.02M | -15.7% |
| Basic shares | 65.55M | 64.83M | — | 59.12M | 58.50M | 58.31M | +1.1% |
| Diluted shares | 65.55M | 64.83M | — | 59.12M | 58.50M | 58.31M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.85B | $2.25B | $306.70M | — | $611.48M | $558.47M | -17.6% |
| Cash & short-term investments | $2.27B | $2.45B | $1.31B | — | $961.48M | $1.03B | -7.4% |
| Accounts receivable | $7.73M | $6.33M | $5.07M | — | $4.72M | $2.93M | +22.2% |
| Inventory | $19.21M | $12.75M | $6.62M | — | $5.77M | $6.24M | +50.7% |
| Total current assets | $2.34B | $2.50B | $1.33B | — | $987.47M | $1.05B | -6.3% |
| Property, plant & equipment | $729.43M | $729.58M | $715.58M | — | $580.46M | $540.02M | -0.0% |
| Goodwill & intangibles | $20.24M | $3.08M | $2.93M | — | $1.89M | $1.85M | +558.1% |
| Total assets | $3.16B | $3.29B | $2.11B | — | $1.66B | $1.68B | -4.1% |
| Total current liabilities | $232.19M | $259.82M | $308.97M | — | $393.94M | $324.56M | -10.6% |
| Current debt | $100.00M | $100.00M | $100.13M | — | $200.00M | $200.00M | 0.0% |
| Total debt | $231.52M | $239.00M | $237.40M | — | $351.10M | $357.97M | -3.1% |
| Total liabilities | $333.59M | $368.95M | $418.27M | — | $517.27M | $454.87M | -9.6% |
| Retained earnings | -$1.80B | -$1.71B | -$1.63B | — | -$1.36B | -$1.28B | -5.2% |
| Shareholder equity | $2.57B | $2.66B | $1.42B | — | $1.04B | $1.12B | -3.3% |
| Working capital | $2.11B | $2.24B | $1.02B | — | $593.53M | $722.21M | -5.8% |
| Net tangible assets | $2.55B | $2.66B | $1.42B | — | $1.04B | $1.11B | -4.0% |
| Shares issued | 65.58M | 64.91M | 59.30M | 59.16M | 58.89M | — | +1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$100.43M | -$87.17M | -$167.23M | -$83.40M | -$77.26M | -15.2% |
| Depreciation & amortisation | $21.60M | $18.91M | $11.60M | $11.83M | $11.77M | +14.2% |
| Stock-based compensation | $0 | $0 | $68.03M | $390.00K | $6.70M | — |
| Change in working capital | -$48.51M | -$45.09M | $5.30M | $7.19M | $5.37M | -7.6% |
| Operating cash flow | -$127.68M | -$114.09M | -$82.55M | -$63.69M | -$59.33M | -11.9% |
| Capital expenditure | -$41.92M | -$54.62M | -$72.54M | -$26.34M | -$51.05M | +23.2% |
| Investing cash flow | -$261.10M | $747.66M | -$512.15M | $86.99M | $191.82M | -134.9% |
| Financing cash flow | -$7.43M | $1.31B | $552.16M | $29.71M | -$1.38M | -100.6% |
| Free cash flow | -$169.60M | -$168.71M | -$155.09M | -$90.03M | -$110.38M | -0.5% |
| End cash position | $1.85B | $2.25B | $306.70M | $611.48M | $558.47M | -17.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions1.40%
Institutions holding8
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
48.47
-6.65% from price
SMA 20
51.74
-12.45% from price
SMA 50
567.36
-92.02% from price
SMA 100
695.46
-93.49% from price
SMA 200
629.63
-92.81% from price
EMA 12
68.40
-33.85% from price
EMA 26
213.33
-78.79% from price
EMA 50
415.83
-89.12% from price
RSI (14)
22.2
Oversold
MACD (12,26,9)
-144.93
Hist 34.74
ATR (14)
2.95
6.50% of price
Realised vol 30D
855.2%
Annualised
Bollinger upper
59.84
20, 2σ
Bollinger lower
43.64
20, 2σ
50 / 200 cross
Death
567.36 vs 629.63
Trend bias
Below 200
-92.81%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.07
More volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
855.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-97.0%
Peak to trough
Max drawdown 5Y
-97.0%
Peak to trough
ATR 14
2.95
6.50% of price
Beta (reported)
1.33
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split20000:1000
Split dateAug 27, 2026
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.